Specific serum Ig recognizing staphylococcal wall teichoic acid induces complement-mediated opsonophagocytosis against Staphylococcus aureus. 2012

Dong-Jun Jung, and Jang-Hyun An, and Kenji Kurokawa, and Yoon-Chuel Jung, and Min-Jung Kim, and Youko Aoyagi, and Misao Matsushita, and Shinji Takahashi, and Hee-Seung Lee, and Kazue Takahashi, and Bok Luel Lee
Global Research Laboratory of Insect Symbiosis, College of Pharmacy, Pusan National University, Jangjeon Dong, Gumjeong Gu, Busan 609-735, Korea.

Wall teichoic acid (WTA) of Staphylococcus aureus is a major cell envelope-associated glycopolymer that is a key molecule in promoting colonization during S. aureus infection. The complement system plays a key role in the opsonization and clearance of pathogens. We recently reported that S. aureus WTA functions as a ligand of human serum mannose-binding lectin (MBL), a recognition molecule of the lectin complement pathway. Intriguingly, serum MBL in adults does not bind to WTA because of an inhibitory effect of serum anti-WTA-IgG. In this study, serum anti-WTA-IgG was purified to homogeneity using a purified S. aureus WTA-coupled affinity column to examine the biological function of human anti-WTA-IgG. The purified anti-WTA-IgG contained the IgG2 subclass as a major component and specifically induced C4 and C3 deposition on the S. aureus surface in the anti-WTA-IgG-depleted serum, but not in C1q-deficient serum. Furthermore, the anti-WTA-IgG-dependent C3 deposition induced phagocytosis of S. aureus cells by human polymorphonuclear leukocytes. These results demonstrate that serum anti-WTA-IgG is a real trigger for the induction of classical complement-dependent opsonophagocytosis against S. aureus. Our results also support the fact that a lack of the lectin complement pathway in MBL-deficient adults is compensated by Ag-specific, Ab-mediated adaptive immunity.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D010587 Phagocytosis The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES). Phagocytoses
D002473 Cell Wall The outermost layer of a cell in most PLANTS; BACTERIA; FUNGI; and ALGAE. The cell wall is usually a rigid structure that lies external to the CELL MEMBRANE, and provides a protective barrier against physical or chemical agents. Cell Walls,Wall, Cell,Walls, Cell
D003171 Complement Pathway, Classical Complement activation initiated by the binding of COMPLEMENT C1 to ANTIGEN-ANTIBODY COMPLEXES at the COMPLEMENT C1Q subunit. This leads to the sequential activation of COMPLEMENT C1R and COMPLEMENT C1S subunits. Activated C1s cleaves COMPLEMENT C4 and COMPLEMENT C2 forming the membrane-bound classical C3 CONVERTASE (C4B2A) and the subsequent C5 CONVERTASE (C4B2A3B) leading to cleavage of COMPLEMENT C5 and the assembly of COMPLEMENT MEMBRANE ATTACK COMPLEX. Classical Complement Pathway,Classical Complement Activation Pathway,Complement Activation Pathway, Classical
D003176 Complement C3 A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase. C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3
D003181 Complement C4 A glycoprotein that is important in the activation of CLASSICAL COMPLEMENT PATHWAY. C4 is cleaved by the activated COMPLEMENT C1S into COMPLEMENT C4A and COMPLEMENT C4B. C4 Complement,C4 Complement Component,Complement 4,Complement C4, Precursor,Complement Component 4,Pro-C4,Pro-complement 4,C4, Complement,Complement Component, C4,Complement, C4,Component 4, Complement,Component, C4 Complement,Pro C4,Pro complement 4
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000907 Antibodies, Bacterial Immunoglobulins produced in a response to BACTERIAL ANTIGENS. Bacterial Antibodies

Related Publications

Dong-Jun Jung, and Jang-Hyun An, and Kenji Kurokawa, and Yoon-Chuel Jung, and Min-Jung Kim, and Youko Aoyagi, and Misao Matsushita, and Shinji Takahashi, and Hee-Seung Lee, and Kazue Takahashi, and Bok Luel Lee
November 2015, Infection and immunity,
Dong-Jun Jung, and Jang-Hyun An, and Kenji Kurokawa, and Yoon-Chuel Jung, and Min-Jung Kim, and Youko Aoyagi, and Misao Matsushita, and Shinji Takahashi, and Hee-Seung Lee, and Kazue Takahashi, and Bok Luel Lee
October 2016, Immunobiology,
Dong-Jun Jung, and Jang-Hyun An, and Kenji Kurokawa, and Yoon-Chuel Jung, and Min-Jung Kim, and Youko Aoyagi, and Misao Matsushita, and Shinji Takahashi, and Hee-Seung Lee, and Kazue Takahashi, and Bok Luel Lee
December 2020, Trends in microbiology,
Dong-Jun Jung, and Jang-Hyun An, and Kenji Kurokawa, and Yoon-Chuel Jung, and Min-Jung Kim, and Youko Aoyagi, and Misao Matsushita, and Shinji Takahashi, and Hee-Seung Lee, and Kazue Takahashi, and Bok Luel Lee
June 2015, mBio,
Dong-Jun Jung, and Jang-Hyun An, and Kenji Kurokawa, and Yoon-Chuel Jung, and Min-Jung Kim, and Youko Aoyagi, and Misao Matsushita, and Shinji Takahashi, and Hee-Seung Lee, and Kazue Takahashi, and Bok Luel Lee
July 2009, Journal of bacteriology,
Dong-Jun Jung, and Jang-Hyun An, and Kenji Kurokawa, and Yoon-Chuel Jung, and Min-Jung Kim, and Youko Aoyagi, and Misao Matsushita, and Shinji Takahashi, and Hee-Seung Lee, and Kazue Takahashi, and Bok Luel Lee
February 2010, International journal of medical microbiology : IJMM,
Dong-Jun Jung, and Jang-Hyun An, and Kenji Kurokawa, and Yoon-Chuel Jung, and Min-Jung Kim, and Youko Aoyagi, and Misao Matsushita, and Shinji Takahashi, and Hee-Seung Lee, and Kazue Takahashi, and Bok Luel Lee
February 2011, Antimicrobial agents and chemotherapy,
Dong-Jun Jung, and Jang-Hyun An, and Kenji Kurokawa, and Yoon-Chuel Jung, and Min-Jung Kim, and Youko Aoyagi, and Misao Matsushita, and Shinji Takahashi, and Hee-Seung Lee, and Kazue Takahashi, and Bok Luel Lee
October 2022, ACS central science,
Dong-Jun Jung, and Jang-Hyun An, and Kenji Kurokawa, and Yoon-Chuel Jung, and Min-Jung Kim, and Youko Aoyagi, and Misao Matsushita, and Shinji Takahashi, and Hee-Seung Lee, and Kazue Takahashi, and Bok Luel Lee
April 2010, The Journal of biological chemistry,
Dong-Jun Jung, and Jang-Hyun An, and Kenji Kurokawa, and Yoon-Chuel Jung, and Min-Jung Kim, and Youko Aoyagi, and Misao Matsushita, and Shinji Takahashi, and Hee-Seung Lee, and Kazue Takahashi, and Bok Luel Lee
March 2010, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!